Cholera’s Comeback vs. ICG’s Supply Chain: A Matter of Life or Death

Posted on

Rising ocean temperatures cause increased proliferation of the Cholera-causing bacteria, Vibrio cholerae, which is “influencing outbreaks on a worldwide scale” [1]. As these outbreaks increase so does the demand for the oral cholera vaccine (OCV). Despite the commitment of organizations like the International Coordinating Group (ICG), unpredictable vaccine demand continues to result in 2.9M cases and 95,000 deaths per year [2]. How can ICG effectively respond to the world’s increasing demand for OCV to prevent unnecessary deaths from a preventable disease?

How Big is Amazon’s Opportunity in Healthcare?

Posted on

In October 2017, reports surfaced stating that Amazon’s entry into healthcare was imminent. Overnight, stock prices for top pharmacies, PBMs, and wholesalers plummeted, losing a sum total of ~$40B in market capitalization [1].

But how well-equipped is Amazon to disrupt the entire healthcare supply chain?

Having worked as a healthcare consultant, and as a member of a family entrenched in the business of healthcare, I can say: this is one of the most critical unknowns facing the industry.